Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Pliant Therapeutics (PLRX) Non-cash Items (2019 - 2020)

Pliant Therapeutics has reported Non-cash Items over the past 2 years, most recently at $736601.0 for Q4 2020.

Quarterly Non-cash Items fell 85.72% to $736601.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $736601.0 through Dec 2020, down 85.72% year-over-year, with the annual reading at $736601.0 for FY2020, 85.72% down from the prior year.
Non-cash Items was $736601.0 for Q4 2020 at Pliant Therapeutics, up from $629988.0 in the prior quarter.
Over five years, Non-cash Items peaked at $5.2 million in Q4 2019 and troughed at $97942.0 in Q2 2019.